Application of Tetrameric Recombinant Human Butyrylcholinesterase as a Biopharmaceutical for Amelioration of Symptoms of Acute Organophosphate Poisoning


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We present a procedure for optimizing the expression of recombinant tetrameric butyrylcholinesterase that enables large-scale production with the yield >30 mg/liter (>90 mg/roller bottle). Intravenous injection of the preparation significantly increased survival and decreased the severity of symptoms of poisoning with paraoxon, an organophosphorus toxin.

Sobre autores

S. Terekhov

V. V. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Autor responsável pela correspondência
Email: sterekhoff@mail.ru
Rússia, Moscow

V. Palikov

Affiliated Branch of V. V. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: sterekhoff@mail.ru
Rússia, Pushchino, Moscow Region

Y. Palikova

Affiliated Branch of V. V. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: sterekhoff@mail.ru
Rússia, Pushchino, Moscow Region

I. Dyachenko

Affiliated Branch of V. V. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: sterekhoff@mail.ru
Rússia, Pushchino, Moscow Region

O. Shamborant

V. V. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: sterekhoff@mail.ru
Rússia, Moscow

I. Smirnov

V. V. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: sterekhoff@mail.ru
Rússia, Moscow

P. Masson

Kazan (Volga Region) Federal University

Email: sterekhoff@mail.ru
Rússia, Republic of Tatarstan, Kazan

A. Gabibov

V. V. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: sterekhoff@mail.ru
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies